A Multicenter, Prospective, Observational, Non-Interventional Cohort Study Evaluating On-Treatment Predictors of Response in Subjects With HBeAg Positive and HBeAg Negative Chronic Hepatitis B Receiving Therapy With PEGASYS(R) (Peginterferon Alfa-2a 40KD)
A Multicenter, Prospective, Observational, Non-Interventional Cohort Study Evaluating On-Treatment Predictors of Response in Subjects With HBeAg Positive and HBeAg Negative Chronic Hepatitis B Receiving Therapy With PEGASYS(R) (Peginterferon Alfa-2a 40KD)
This observational, non-interventional cohort study will evaluate predictors of response in patients with chronic hepatitis B receiving standard of care Pegasys therapy. Efficacy and safety parameters will also be evaluated. Patients included in the study will be followed for the duration of their treatment and for up to 3 years thereafter.
Inclusion Criteria:
Exclusion Criteria:
Innsbruck, 6020, Austria
Vienna, 1090, Austria
Banja Luka, 78000, Bosnia and Herzegovina
Sofia, 1407, Bulgaria
Xi'an, 710038, China
Berlin, 10117, Germany
Berlin, 12203, Germany
Berlin, 13353, Germany
Berlin, 13353, Germany
Düsseldorf, 40225, Germany
Freiburg im Breisgau, 79106, Germany
Giessen, 35392, Germany
Hanover, 30625, Germany
Kiel, 24105, Germany
Lübeck, 23562, Germany
Magdeburg, 39120, Germany
München, 81675, Germany
Münster, 48149, Germany
Ulm, 89081, Germany
Dublin, 7, Ireland
Krakow, 31-202, Poland
Lodz, 91-347, Poland
Lodz, 91-347, Poland
Warsaw, 01-201, Poland
Bucharest, 021105, Romania
Craiova, 200515, Romania
Chooncheon, 200-060, South Korea
Jeollabuk-do, 561-712, South Korea
Seoul, 120-752, South Korea
Seoungnamsi, 463-824, South Korea